Hypoplastic Left Heart Syndrome Birth Defects

Hypoplastic Left Heart Syndrome Birth Defects

Hypoplastic left heart syndrome is a birth defect that occurs when parts of the left side of the heart (mitral valve, left ventricle, aortic valve, and aorta) do not develop completely. As a result, the left side of the heart is unable to send enough blood to the body. To compensate, the right side of the heart must maintain the circulation for both the lungs and the body. Eventually, the added strain will result in the failure of the right side of the heart.

At first, a newborn with hypoplastic left heart syndrome may appear normal. Symptoms usually occur in the first few hours of life, although it may take up to a few days to develop symptoms. These symptoms may include:

  • Bluish (cyanosis) or poor skin color
  • Cold hands and feet (extremities)
  • Lethargy
  • Poor pulse
  • Poor suckling and feeding
  • Pounding heart
  • Rapid breathing
  • Shortness of breath

Babies with hypoplastic left heart syndrome must be admitted to the neonatal intensive care unit, and may need a breathing machine (ventilator) to assist their breathing. A medicine called prostaglandin E1 is used to keep blood circulating to the body by keeping the ductus arteriosus open. Once stabilized, the baby will need to undergo a two-phase surgical procedure to correct the condition. The first, called the Norwood operation, occurs within the baby’s first few days of life, and consists of building a new artery. The second stage is called the Glenn shunt or hemi-Fontan procedure, and connects the major vein carrying blue blood from the top half of the body (the superior vena cava) directly to blood vessels to the lungs (pulmonary arteries) to get oxygen. The surgery is usually done when the child is 4 to 6 months of age. Between the two phases, the baby usually is able to go home, but will need medications and close monitoring.

Defective Drugs That May Cause Hypoplastic Left Heart Syndrome Birth Defect

The leading law firm of Alonso Krangle LLP is investigating potential lawsuits on behalf of families whose child may have been born with hypoplastic left heart syndrome because of their mother’s use of a drug. A growing body of research has linked the use of SSRI antidepressants to birth defects, including hypoplastic left heart syndrome, and Proton Pump Inhibitors PPI’s.

SSRIs that may be associated with the occurrence of hypoplastic left heart syndrome include:

  • Celexa
  • Lexapro
  • Paxil
  • Prozac
  • Zoloft

PPIs that may be associated with the occurrence of hypoplastic left heart syndrome include:

  • Prilosec
  • Nexium
  • Prevacid
  • Aciphex
  • Dexilant
  • Kapidex
  • Vimovo
  • Protonix
  • Zegerid

Learn more About Filing a Hypoplastic Left Heart Syndrome Lawsuit

The birth defect lawyers at Alonso Krangle LLP are leaders in defective drug litigation, and understand how devastating having a child with hypoplastic left heart syndrome can be. If your child’s suffering was caused by a defective drug taken during pregnancy, filing a  hypoplastic left heart syndrome lawsuit could enable you to obtain money damages for your child’s current and future medical needs, pain and suffering, and emotional distress. The birth defect lawyers at Alonso Krangle LLP are currently offering free lawsuit consultations in all 50 states to any family who believes a defective drug caused their baby to suffer from hypoplastic left heart syndrome. If your child was born with hypoplastic left heart syndrome, and defective drug might be to blame, you may be eligible to file a lawsuit against the manufacturers of these medications. To learn more about obtaining justice for your baby, or the legal options available to you, please contact the birth defect lawyers at Alonso Krangle LLP by filling out our online form or calling 1-800-403-6191.